MatsukiyoCocokara & Co.

3088.T
Pharmaceutical Retailers
2026/06/05 Updated
Market Cap: $5.7B (¥912.4B)
Stock Price: $14.31 (¥2,293)
Exchange Rate: 1 USD = ¥160.26

Stock Price Chart

2026/06/05 Updated
16.40
PER (Price Earnings Ratio)
vs Industry Avg: +6.8
1.68
PBR (Price to Book Ratio)
vs Industry Avg: +0.4
2.45%
Dividend Yield
vs Industry Avg: -0.50%

Price Trend

2026/06/05 Updated
Short-term
5-Day MA
+0.52%
Near-term
25-Day MA
+0.67%
Mid-term
75-Day MA
-4.64%
Long-term
200-Day MA
-14.39%

Price & Trading Details

2026/06/05 Updated

PRICE

Previous Close ¥2,285
Open ¥2,286
High ¥2,326
Low ¥2,280
Close ¥2,293

TRADING

Volume 1,712,300
Average Volume 2,784,431
Turnover ¥39億
Min. Purchase ¥229,300

Analyst Recommendations 10 analysts

Updated 2026/06/05
Strong Buy
2
2
Buy
5
5
Hold
3
3
Sell
0
Strong Sell
0
Target Price (Mean)
¥2,979
Buy
¥3,500
High
¥2,975
Median
¥2,450
Low
+7% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/06/05
13.9%
Insider Holdings
42.5%
Institutional
43.7%
Public Float
258
Institutional Holders
Insider Holdings 13.9%
Institutional 42.5%
Public Float 43.7%

Major Holders

Updated 2026/06/05
Institution Ownership Shares Change
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.24%
5.0M +1.06%
-Price (T.Rowe) International Value Equity Trust
0.98%
4.0M +0.32%
Columbia Funds Series Trust-Columbia Overseas Value Fund
0.95%
3.8M +7.03%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.79%
3.2M +2.04%
T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Value Eqy. Fd.
0.72%
2.9M -2.52%
Columbia Fd.s Varbl Series TRT II-Columbia Varbl PORT. - Overseas Core
0.68%
2.8M -10.20%

Dividend History

Updated 2026/06/04
-%
Dividend Yield
¥26
Annual Dividend
-44.7%
YoY Growth
19.4%
Payout Ratio
Year Dividend Change
2026 ¥26 -44.7%
2025 ¥47 +14.6%
2024 ¥41 +36.7%
2023 ¥30 +20.0%
2022 ¥25 -

Financial Performance

2026/06/04 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥729,969M ¥951,247M ¥1,022,531M ¥1,061,626M
Gross Profit ¥239,979M ¥329,320M ¥354,097M ¥372,235M
Operating Income ¥41,095M ¥62,280M ¥75,710M ¥82,086M
Pretax Income ¥49,374M ¥64,961M ¥81,303M ¥83,958M
Net Income ¥34,377M ¥40,545M ¥52,347M ¥54,675M
EPS ¥93.78 ¥95.99 ¥125.28 ¥133.81
Operating Margin 5.63% 6.55% 7.40% 7.73%
Balance Sheet
Total Assets ¥652,524M ¥688,132M ¥724,747M ¥712,780M
Total Equity ¥460,104M ¥482,470M ¥514,727M ¥520,796M
Total Liabilities ¥192,420M ¥205,662M ¥210,020M ¥191,984M
Cash ¥74,519M ¥95,224M ¥117,720M ¥111,750M
Interest-bearing Debt ¥22,920M ¥21,412M ¥20,663M ¥2,205M
Equity Ratio 70.51% 70.11% 71.02% 73.07%
D/E Ratio 0.05 0.04 0.04 0.00
Cash Flow
Operating CF ¥39,812M ¥64,061M ¥63,506M ¥81,472M
Investing CF -¥15,485M -¥19,669M -¥22,760M -¥20,792M
Financing CF -¥20,337M -¥23,734M -¥18,273M -¥66,662M
Free CF ¥28,846M ¥47,315M ¥43,393M ¥67,014M
Efficiency
ROE 7.47% 8.40% 10.17% 10.50%
ROA 5.27% 5.89% 7.22% 7.67%

Latest IR Information

Latest News (5 items)

  • June 7, 2026
    Analyst Rating

    Average Analyst Rating: buy

    Average Target Price: ¥2,979
    Rating Score: 1.80 (Based on 10 analysts)
    ※1=Strong Buy, 5=Strong Sell

Company Information

English Name MatsukiyoCocokara & Co.
Japanese Name (株)マツキヨココカラ＆カンパニー
Stock Code 3088.T (JPX)
Sector / Industry Healthcare / Pharmaceutical Retailers
Website https://www.matsukiyococokara.com

About

MatsukiyoCocokara & Co. operates and manages chain stores, drug stores, and insurance dispensing pharmacies in Japan. The company is involved in the franchise business development and product supply to franchisees. It offers its products under the nake and RECiPEO brand names. MatsukiyoCocokara & Co. was founded in 1932 and is headquartered in Tokyo, Japan.

Data provided by Yahoo Finance

Never Miss Important IR Events

Covering 3,799 companies. AI summaries delivered instantly.

Get Free Alerts